参考文献/References:
1. Carter G et al. Br J Cancer,1993;67:869-876
2. Evans HJ. Br J Cancer,1993;68:1051-1060
3. Katharine AW. Lab Invest,1995;72:131-145
4. Dewanjee MK et al. J Nucl Med,1994;35:42 p
5. Dewanjee MK et al. J Nucl Med,1993;34:224 p
6. Dewanjee MK et al. J Nucl Med,1994;35:1054-1063
7. Dewanjee MK et al. J Nucl Med,1994;335:65 p
8. Urbain JL et al. J Nucl Med,1994;35:65p
9. Dewanjee MK et al. J Nucl Med,1993;34:174
10. David PW et al. J Nucl Med,1994;35:1064-1066
11. Lu XM et al. J Nucl Med,1994;35:269-375
12. Ian TM. Int J Cancer,1994;56:163-166
13. Michael SI et al. Gene Therapy,1994;1:223-232
相似文献/References:
[1]邹跃,周湘艳.端粒酶在肿瘤临床诊治中的应用前景[J].国际放射医学核医学杂志,2003,27(3):141.
ZOU Yue,ZHOU Xiang-yan.The prospects of clinical application of telomerase in tumor diagnosis and tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(3):141.
[2]夏劲松.反义显像技术的研究进展[J].国际放射医学核医学杂志,2001,25(2):62.
XIA Jin-song.Progression of antisense oligonucleotides for non-invasive imaging in vivo[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(3):62.
[3]杨卫东,朱承谟.肿瘤反义显像技术中的若干问题[J].国际放射医学核医学杂志,1998,22(6):244.
[4]赵军,林祥通.18F-FDG PET诊断肿瘤应考虑的几个问题[J].国际放射医学核医学杂志,1999,23(6):241.
[5]秦光明.肿瘤核素反义显像技术的研究现状与展望[J].国际放射医学核医学杂志,2001,25(5):213.
QIN Guang-ming.Current researches and prospective of radiolabeled antisense imaging in tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(3):213.